Novo’s has fallen by as much (see chart 2). Lilly’s edge rests on a more effective drug, better execution, some keener pricing and a stronger pipeline. Zepbound and Wegovy belong to a class of ...

Cuban annual raw sugar production will fall below 200,000 metric tons in 2025 for the first time since the 19th century, ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

"The highest dose of tirzepatide is five times higher than the approved maximum doses of semaglutide," said Novo Nordisk adding that in the trial, the among of weight loss for Wegovy was lower ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

(RTTNews) - Eli Lilly and Co. (LLY) announced that Zepbound (tirzepatide) demonstrated a significantly greater weight reduction compared to Wegovy (semaglutide) in all comparisons conducted during ...